153 related articles for article (PubMed ID: 15681796)
1. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization.
Wildner G; Thurau SR; Diedrichs-Möhring M
Ann N Y Acad Sci; 2004 Dec; 1029():416-21. PubMed ID: 15681796
[TBL] [Abstract][Full Text] [Related]
2. Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis.
Wildner G; Hünig T; Thurau SR
Eur J Immunol; 1996 Sep; 26(9):2140-8. PubMed ID: 8814259
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
Laliotou B; Duncan L; Dick AD
J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
Wildner G; Thurau SR
Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
Diedrichs-Möhring M; Wildner G
Immunobiology; 2005; 209(10):711-7. PubMed ID: 15969447
[TBL] [Abstract][Full Text] [Related]
6. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.
Breban M; Fernández-Sueiro JL; Richardson JA; Hadavand RR; Maika SD; Hammer RE; Taurog JD
J Immunol; 1996 Jan; 156(2):794-803. PubMed ID: 8543835
[TBL] [Abstract][Full Text] [Related]
7. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
Wildner G; Diedrichs-Möhring M
Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
[TBL] [Abstract][Full Text] [Related]
8. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of the contact sensitivity reaction by suppression of T gamma delta lymphocytes].
Szczepanik M
Folia Med Cracov; 1998; 39(1-2):5-33. PubMed ID: 10481375
[TBL] [Abstract][Full Text] [Related]
10. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
Sunil S; Eto K; Singh VK; Shinohara T
Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
[TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
Eto K; Suzuki S; Singh VK; Shinohara T
Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
[TBL] [Abstract][Full Text] [Related]
12. Rat models of autoimmune uveitis.
Wildner G; Diedrichs-Mohring M; Thurau SR
Ophthalmic Res; 2008; 40(3-4):141-4. PubMed ID: 18421228
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
Singh VK; Anand R; Sharma K; Agarwal SS
Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
[TBL] [Abstract][Full Text] [Related]
14. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
[TBL] [Abstract][Full Text] [Related]
16. Rodent models of experimental autoimmune uveitis.
Agarwal RK; Caspi RR
Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
[TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis.
Singh VK; Yamaki K; Donoso LA; Shinohara T
J Immunol; 1989 Mar; 142(5):1512-7. PubMed ID: 2645363
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat.
Caspi RR; Kuwabara T; Nussenblatt RB
J Immunol; 1988 Apr; 140(8):2579-84. PubMed ID: 2965724
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitis.
Thurau SR; Fricke H; Burchardi C; Diedrichs-Möhring M; Wildner G
Ann N Y Acad Sci; 2004 Dec; 1029():408-12. PubMed ID: 15681794
[TBL] [Abstract][Full Text] [Related]
20. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.
Wildner G; Diedrichs-Möhring M; Thurau SR
Eur J Immunol; 2002 Jan; 32(1):299-306. PubMed ID: 11782021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
